Hepatitis B Vaccine
Hepatitis B vaccine plus lamivudine did not eliminate viral DNA
Published in Hepatitis Weekly, August 30th, 2004
"We report the first case of a woman having chronic hepatitis B treated with a combination therapy of recombinant hepatitis B vaccine and lamivudine for 18 months. The main aims of such a combined therapy were to assess whether the concomitant anti-hepatitis B virus (HBV) vaccination might prevent the emergence of a mutant HBV and lead to sustained hepatitis B e antigen seroconversion with undetectable serum HBV DNA," scientists in Turkey report.
"The data from the present case demonstrated that combination of anti-HBV...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-08-30)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Pegylated interferon and ribavirin cures many with hepatitis C virus infection - Immunology
Tests for anti-E2 antibody enhance hepatitis C detection in dialysis patients - Renal Transplant
Ultralow-dose interferon plus ribavirin helps HCV-positive kidney recipients - Transfusion Medicine
Blood donation may be a source of hepatitis E virus transmissions in Japan - Virology
NS5A protein confers a multiplicative advantage to hepatitis C virus - Business & Finance
LymphoStat-B maker reports losses, milestones in Q2 2004 - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
